Literature DB >> 15779008

TSH receptor protein is selectively expressed in normal human extraocular muscle.

Steven J Kloprogge1, Bridget E Busuttil, Albert G Frauman.   

Abstract

Thyroid-associated ophthalmopathy is a common manifestation of Graves' disease. Its pathophysiology is not well understood but an antigen shared between the thyroid and orbit is thought to play a role. Using immunohistochemistry, we have demonstrated the presence of the autoantigenic target of Graves' disease, the thyroid-stimulating hormone receptor, in normal human extraocular muscle. These results support previous findings of the full length and splice variant thyroid-stimulating hormone receptor cDNA in extraocular muscle. The observation of the autoimmune target--the thyroid-stimulating hormone receptor protein--being shared between the thyroid and extraocular muscle lends greater support to the notion that an extraocular muscle thyroid-stimulating hormone receptor is also a likely target autoantigen in thyroid-associated ophthalmopathy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15779008     DOI: 10.1002/mus.20315

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  4 in total

1.  Expression of TSH-R in normal human extraocular muscles.

Authors:  S J Kloprogge; A G Frauman
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

Review 2.  Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy.

Authors:  Yao Wang; Terry J Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-20       Impact factor: 4.799

3.  Determinants of extraocular muscle volume in patients with graves' disease.

Authors:  Samer El-Kaissi; Jack R Wall
Journal:  J Thyroid Res       Date:  2012-02-15

4.  Expression of Thyroid Stimulating Hormone Receptor mRNA in Mouse C2C12 Skeletal Muscle Cells.

Authors:  Jung Hun Ohn; Sun Kyoung Han; Do Joon Park; Kyong Soo Park; Young Joo Park
Journal:  Endocrinol Metab (Seoul)       Date:  2013-06-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.